UCP1 and obesity disorder: This study provides evidence that combining β3-adrenergic stimulation with PPARα activation can promote metabolic effects that stimulate energy expenditure, including UCP1-mediated thermogenesis, providing a potential therapeutic approach for the treatment of obesity.